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ABSTRACT.  
The standard of treatment of the patients with acute ischemic stroke within the "therapeutic window" is systemic 
thrombolysis. However, there are many contraindications and limitations of this method of treatment use. An 
alternative is endovascular thrombectomy, and a number of large studies showed that such treatment is most 
effective to improve functional and clinical outcomes at the "proximal" lesion of large vessels. The article 
analyzed the literature on the largest studies related to endovascular thrombectomy. The endovascular treatment of 
group of patients with ischemic stroke was performed due to the occlusions of large cerebral vessels. The 
technique of various types of endovascular thrombectomy performance is described: aspirational and mechanical 
one. The effectiveness and complications of endovascular thrombectomy were analyzed. The obtained results 
show the reduction in mortality and disability among the patients after endovascular treatment. 
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INTRODUCTION.
 Vascular diseases of brain are an actual medical 
and social problem. The stroke hits more than 6 
million people every year worldwide, and 
according to the World Health Organization 
(WHO) the number of deaths from stroke 
increased from 5.41 million to 6.24 million per 
year from 2000 to 2015 [1]. The frequency of 
stroke in the Belgorod region makes 3.42 per 
1000 of people [2]. The mortality from stroke 
among the people of working age increased by 
more than 30% in Russian Federation over the 
past 10 years. The annual death rate from stroke 
in our country makes 175 cases per 100 000 of 
population. In addition to high mortality, this 
disease leads to persistent disability - from 15 to 
30% of patients with acute cerebrovascular 
accident (ACVA) remain disabled for life [3,4]. 
The disability rate after a stroke makes 56-81% 
on the average in the country. The development 
of acute cerebral ischemia triggers the cascade 
of pathological biochemical reactions, resulting 
in neuron damage and death [5]. One solution to 
the problem is a rapid and an effective brain 
reperfusion. Systemic thrombolytic therapy with 
the use of recombinant tissue plasminogen 
activator (rt-PA) is the standard for medical care 
provision, in accordance with the 
recommendations of the European Stroke 
Organization (ESO) and the American Heart 
Association and the Stroke Association 
(AHA/ASA) it is assigned to patients during the 
first 4.5 h after the manifestation of neurological 
symptoms [6]. However, there is a number of 
limitations and contraindications to the use of 
this method. The markers of functional well-
being and lethality are recanalization indicators, 
such as the rate of blood flow recovery and the 
efficiency of a thrombus destruction (removal). 
With the occlusion of large vessels (internal 
carotid (BCA), vertebral artery (VA), basilar 
artery (BA) and middle cerebral artery (MCA)) 
the recanalization rates are low. Thus, the 
effectiveness of systemic thrombolysis with the 
occlusion of ICA is observed in 14% of cases, 
with MCA occlusion in 55% of cases [7, 8]. 
Endovascular thrombectomy became an 
alternative and complementary method of 
treatment. The first evidence of endovascular 
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thrombectomy efficiency for the treatment of 
stroke was a multicenter, randomized clinical 
trial of endovascular treatment of acute ischemic 
stroke in the Netherlands (MR CLEAN). 
Subsequently, other studies emerged that 
confirmed the advantage of endovascular 
treatment among the patients with large cerebral 
vessel occlusion (Table 1) [9-11]. 
Table 1. The effectiveness of endovascular methods of treatment use  
Study name 
Number of 
patients 
Frequency of 
stent-retriever 
application 
Effective 
reperfusion TICI 
2b-3 
Clinical outcome mRS 0-2 
Intervention group 
Control 
group 
MR CLEAN 500 81.5% 58.70% 33% 19% 
ESCAPE 315 86.1% 72.40% 53% 29% 
EXTEND IA 70 100.0% 86% 71% 40% 
SWIFT-PRIME 196 100.0% 88% 60% 35% 
REVACAST 206 95.1% 65.70% 44% 28% 
 
A rapid recanalization is one of the most important factors of a good clinical outcome among the 
patients with an acute occlusion of large vessels [12]. 
The aim of our work is to evaluate the effectiveness of endovascular thrombectomy application among 
the patients with acute cerebrovascular accident. 
 
Methodology. The study included 45 patients (11 women, 34 men, the mean age made 63 years) with 
an acute occlusion of brain large vessels, who underwent endovascular thrombectomy. In order to 
determine the tactics of treatment for all patients, a computed tomography (CT) scan was performed to 
determine the site of ischemia and to exclude intracerebral hemorrhage. In the absence of a large 
outbreak of ischemia (no more than 1/3 of the basin), an intracerebral hemorrhage, the patient was 
transported to the X-ray room. The average time from the onset of neurologic symptoms to 
endovascular intervention in the carotid basin made 299 minutes. (The shortest time is 1 hour 20 
minutes, the maximum one is 48 hours), 1035 min in the vertebrobasilar basin. The average score on 
NIHSS scale (National Institutes of Health Stroke Scale) was 11.5 points. 
21 cases (47%) demonstrated cardioembolic clinical subtype, 20 cases (45%) showed atherothrombotic 
subtype, 2 cases (4%) showed cryptogenic subtype, 2 cases (4%) demonstrated transient ischemic attack 
(TIA), accompanied by the occlusion of СMA and VA. Concomitant pathology: acute myocardial 
infarction in anamnesis among 7, ischemic heart disease among 29, hypertension among 43, 
hypercholesterolemia among 12, stroke, TIA in history among 5, rhythm disturbances among 21, 
diabetes mellitus among 6 patients. 
In all observations (100%) the ascending aorta is catheterized using femoral access. Using a diagnostic 
catheter, both common carotid, vertebral arteries are catheterized alternately selectively. A selective 
angiography of the main arteries of the head was performed in standard projections. The localization of 
the lesion is presented in Table 2. 
Table 2. Lesion localization. 
Localization  General 
carotid 
artery 
ICA MCA VA Combination of 
basins Opening С7 С4-С1 М1 М2 М1-М2 
Number 2 6 4 7 11 3 5 4 3 
 
Then, the microconductor and the microcatheter 
were inserted into the distal channel. 
Recanalization of occlusion with a 
microconductor was performed, the 
microcatheter was wound up behind the 
occlusion zone. In order to assess the passage of 
the distal channel, angiography was carried out 
through a microcatheter. 
Main part. Aspiration revascularization with 
Penumbra drug was performed for 9 patients 
(20%). The microcatheter and the 
microconductor were wound up beyond the 
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occlusion zone, the patency of the distal bed was 
assessed. Then, the aspiration catheter along the 
axial system was brought to the occlusion zone, 
the aspiration pump was turned on, 
thrombectomy was performed. The coaxial 
system consists of a guide-introducer with a 
large internal lumen for free passage of an 
aspiration catheter and the aspiration catheter 
itself. The use of the coaxial system is necessary 
to overcome anatomical bends and conduct 
wide-lumen catheters to the occlusion zone 
successfully. The mechanical thrombectomy by 
the stent-retriever Solitaire was used among 36 
patients (80%). After the evaluation of the distal 
bed, along the microcatheter behind the 
occlusion zone a stent retriever was fed to the 
distal section of the microcatheter. A 
microcatheter was pulled down by 2/3 from the 
stent retriever in 3-5 minutes for better "capture" 
and the consolidation of the thrombus between 
the stent cells. We used a Cello hydra-catheter, 
which was inflated to the diameter of the artery 
before the removal of a stent retriever for the 
prevention of distal embolism. Then, the traction 
of the stent retriever system and microcatheter 
was performed. After the removal of the stent-
retriever, additional aspiration of 10 ml of blood 
should be performed to prevent distal embolism 
by a fragmented thrombus. In 11 (24%) 
observations at the presence of significant 
stenosis or two-level occlusion, thrombectomy 
was supplemented with stenting. 
The efficacy of endovascular reperfusion 
therapy was evaluated according to the TICI 
(The Thrombolysis in Cerebral Infarction) scale: 
TICI 0 - Absence of restored blood flow; TICI 1 
- restoration of blood flow outside primary 
occlusion, limited filling of distal branches; 
TICI 2a - restoration of blood flow with 
incomplete or delayed blood flow for less than 
50% of the middle cerebral artery basin; TICI 2 
b - restoration of blood flow with incomplete or 
delayed blood flow for more than 50% of the 
middle cerebral artery basin; TICI 3 - complete 
restoration of blood flow with the filling of all 
distal branches of the middle cerebral artery, 
including M3 and M4 segments. 
Our results: TICI 2b-3 blood flow recovery was 
achieved among 28 patients (62%), TICI 1-2a 
blood flow was achieved among 7 patients 
(16%), the absence of blood flow was observed 
among 10 patients (22%). 2 patients could not 
recanalize the occlusion, thrombus aspiration 
with ADAPT technique (A Direct Aspiration 
first Pass Technique) was performed: thrombus 
capture by a negative pressure creation in the 
aspiration catheter and the catheter traction from 
the intracranial arteries.  
Table 3. Results of endovascular treatment 
 
12 cases (27%) showed distal embolism and 
mechanical thrombectomy was supplemented 
with selective thrombolytic therapy using the 
drug Actilease ® (Boehringer Ingelheim). The 
dose of the administered drug was no more than 
25% of the total permissible dose of 
thrombolytic - 0.9 mg/kg of the patient's weight. 
In 4 (8%) cases, dissection was noted: in 2 cases 
at the place of thrombus extraction, in 2 cases at 
the edge of the implanted stents. In all cases 
stent implantation was performed. In 1 case 
there was a detachment of the stent-retriever. 
During the postoperative period, 11 patients 
(24%) developed hemorrhagic transformation of 
the ischemic focus in the form of hemorrhagic 
infarction of 1st and 2nd type according to 
ECASS. Fatal outcome was observed among 8 
(18%) patients, among these patients 3 patients 
had the hemorrhagic transformation in the form 
of parenchymal hematoma with the 
breakthrough of blood into the ventricular 
system developed, 1 patient had hemorrhagic 
transformation in the form of parenchymal 
hematoma of type 1, 4 patients had edema and 
the dislocation of stem structures. 
 
Summary. Our study shows that endovascular 
thrombectomy gives a good clinical result: 
among the patients who left, the NIHSS average 
score at the discharge made 7 points. Functional 
independence (0-2 points by Rankin scale) was 
observed among 28 patients (60%), which 
corresponds to the results of such large studies 
Restorative blood flow TICI 0 TICI 1-2a TICI 2b-3 
Number of patients 10 (22%) 7 (16%) 28 (62%) 
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of endovascular intervention during a stroke as 
SWIFT PRIME, ESCAPE. 
 
CONCLUSIONS.  
Endovascular thrombectomy is an effective 
method of patient treatment with an acute 
occlusion of large cerebral vessels. During the 
verification of "proximal" lesions in the time 
interval up to 4.5 hours, we consider it is 
expedient to apply the thrombectomy primarily. 
The application of this method of treatment is 
also effective at later periods of the therapeutic 
window. 
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